반응식
[CH3:1][O:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][C:12]=1[O:13][CH3:14])[CH:9]=[N:8][C:7]([C:15]([NH:17][C:18]1[NH:22][C:21]3[CH:23]=[C:24]([O:30][CH2:31][CH3:32])[CH:25]=[C:26]([C:27]([OH:29])=O)[C:20]=3[N:19]=1)=[O:16])=[CH:6]2.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.S(O)(O)(=O)=O.[NH2:71][C:72]1[NH:73][CH:74]=[CH:75][N:76]=1>CN(C=O)C.[Cl-].[Na+].O>[CH2:31]([O:30][C:24]1[CH:25]=[C:26]([C:27](=[O:29])[NH:71][C:72]2[NH:73][CH:74]=[CH:75][N:76]=2)[C:20]2[NH:19][C:18]([NH:17][C:15]([C:7]3[N:8]=[CH:9][C:10]4[C:5]([CH:6]=3)=[CH:4][C:3]([O:2][CH3:1])=[C:12]([O:13][CH3:14])[CH:11]=4)=[O:16])=[N:22][C:21]=2[CH:23]=1)[CH3:32]참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
100 mg (0.25 mmol) of 2-[(6,7-dimethoxy-isoquinoline-3-carbonyl)-amino]-6-ethoxy-1H-benzoimidazole-4-carboxylic acid and 200 mg (0.53 mmol) of HBTU were dissolved in 1.0 mL of DMF and 0.5 mL of DIEA and treated with 200 mg (1.5 mmol) of 2-aminoimidazole sulfate as described in general procedure A. Upon completion, the reaction was diluted with brine. The resulting solid was filtered, washed with water and EtOAc, and dried under vacuum to produce 60 mg (47%) of 6,7-dimethoxy-isoquinoline-3-carboxylic acid [5-ethoxy-7-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide. LCMS: 502 (M+1)+.
후처리
- filtrationThe resulting solid was filtered
- washwashed with water and EtOAc
- customdried under vacuum
출처 및 근거
- ORD 기록
- ord-25fb124bfa844b6187b0c8fb369ca848
- 출처 데이터셋
- uspto-grants-2015_02
- 특허 번호
- US08946259B2
연결된 노트
불러오는 중…